Phase II trial of sorafenib in esophageal (E) and gastroesophageal junction (GEJ) cancer: Response observed in adenocarcinoma Meeting Abstract

  

Authors:	Ilson, D.; Janjigian, Y. Y.; Shah, M. A.; Tang, L. H.; Kelsen, D. P.; Campbell, J.; Fuqua, L.
Abstract Title:	Phase II trial of sorafenib in esophageal (E) and gastroesophageal junction (GEJ) cancer: Response observed in adenocarcinoma
Meeting Title:	2011 Gastrointestinal Cancers Symposium
Journal Title:	Journal of Clinical Oncology
Volume:	29
Issue:	4 Suppl.
Meeting Dates:	2011 Jan 20-22
Meeting Location:	San Francisco, CA
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2011-02-01
Language:	English
ACCESSION:	WOS:000208847100041
DOI:	10.1200/jco.2011.29.4_suppl.41
PROVIDER:	wos
Notes:	Meeting Abstract: 41 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/141338